aerovatetx.com (JBIO) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Aerovate Therapeutics Inc (JBIO) o'pka tomir kasalliklari uchun innovatsion inhalatsion terapiyalarni ishlab chiqadi. Rahbariyat klinik muvaffaqiyatsizliklardan so'ng rivojlanish strategiyasini qayta ko'rib chiqib, kapital taqsimotida shaffoflikni ta'minladi. GURU.Markets saytidagi ushbu grafik 0.00 qiymatini aks ettiradi, biznes esa joriy savdolarsiz tadqiqot va ishlanmalarga (R&D) tayanadi, bu esa investitsiya resurslarining tez sur'atlarda sarflanishiga olib kelmoqda.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvypeoku.ae-7b8ozy8&start=20220704&end=20261102&filename=GURU_Markets_-_JBIO_-_Aerovate-Therapeutics-Inc_-_Long-Term-Debt-to-Capital "JBIO: Aerovate Uzoq muddatli qarzning kapitalga nisbati 30.04.2025 - 01.11.2026 | 👁️GURU.Markets👁️")
Aerovate Therapeutics, Inc. (JBIO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Aerovate Therapeutics Inc|JBIO - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Aerovate|JBIO - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Aerovate Therapeutics|JBIO - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Aerovate Therapeutics Inc|Tezkor likvidlik ko‘rsatkichi aerovatetx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:aerovatetx.com - JBIO
Ushbu koeffitsiyent uzoq muddatli majburiyatlarni kapital bilan solishtirgan holda moliyaviy barqarorlik va foiz xarajatlari risklarini baholash orqali, kompaniyaning bir yildan ortiq muddatga ega bo'lgan qarz moliyalashtirishga qaramlik darajasini belgilaydi. Uzoq muddatli qarzning kapitalga nisbatini tahlil qilish orqali investor Aerovate Therapeutics Inc (JBIO) o'zining o'pka arteriya gipertenziyasi terapiyasi uchun innovatsion inhalatsion dori vositalarining ishlab chiqilishini qanchalik agressiv tarzda moliyalashtirayotganini baholashi mumkin.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|PVLA - Uzoq muddatli qarzning kapitalga nisbati|SVRA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati rigel.com (RIGL)|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|ATXS: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati enGene Bio (ENGN)|RAPT - Uzoq muddatli majburiyatlarning kapitalga nisbati|Aclaris Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|kyvernatx.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Tiziana Life Sciences Ltd - Uzoq muddatli qarzning kapitalga nisbati|CABA - Uzoq muddatli qarzning kapitalga nisbati|VTYX (Ventyx Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THTX: Uzoq muddatli kreditlarning kapitalga nisbati|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati eledon.com ELDN|Uzoq muddatli qarzning o'z kapitaliga nisbati AGEN (Agenus Inc.)|CLYM (Climb Bio Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Zura Bio Limited - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati ATYR (aTyr Pharmaceuticals)|Adagene Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti IMA (ImageneBio Inc)|STTK: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Equillium (EQ)|Uzoq muddatli qarzning o'z kapitaliga nisbati Connect Biopharma Holdings|IMUX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ATRA|Uzoq muddatli qarzning kapitalga nisbati inflarx.de (IFRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc. XFOR|ACET (Adicet Bio Inc.) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati INmune Bio Corporation|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|kezarlifesciences.com (KZR) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SABS|AKTX (Akari Therapeutics PLC) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzdorlikning kapitalga nisbati q32bio.com|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|EDSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|IBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Carisma Therapeutics CARM|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Bolt Biotherapeutics, Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Aptevo (APVO) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|aditxt.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|XRTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|HIND - Uzoq muddatli qarzning o'z kapitaliga nisbati|revbiosciences.com - Uzoq muddatli kreditlarning kapitalga nisbati|INDP: Uzoq muddatli qarzning kapitalga nisbati|SCNI (Scinai Immunotherapeutics Ltd) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Affimed Therapeutics (AFMD) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|HOOK - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|ITOS (iTeos Therapeutics Inc) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|THRD: Uzoq muddatli qarzning kapitalga nisbati